Evaluation of eritoran tetrasodium (E5564), a TLR4 antagonist, on the QTc interval in healthy subjects

Benzer Materyaller

• Influence of severity of illness on the effects of eritoran tetrasodium (E5564), a TLR4 antagonist, in patients with severe sepsis
  Yazar:: Opal, SM, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Inhibition of Corneal Inflammation by the TLR4 Antagonist Eritoran Tetrasodium (E5564)
  Yazar:: Sun, Yan, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)
• Use of a screening authorization and randomization center for severe sepsis patient qualification and real-time enrollment in a phase 2 trial of eritoran tetrasodium (E5564), a TLR4 antagonist
  Yazar:: Schentag, J, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Safety, pharmacokinetics, and pharmacodynamics of 4-hour intravenous infusion of eritoran tetrasodium in healthy Japanese and Caucasian males
  Yazar:: Okubo, Y, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Eritoran tetrasodium (E5564) Treatment for Sepsis: Review of Preclinical and Clinical Studies
  Yazar:: Barochia, Amisha, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)